UNSPSC 51112606: Lomustine

This classification denotes a nitrosourea compound with the molecular formula C9H16ClN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7BRF0Z81KG, chemically known as 1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl- but more generally known as lomustine, which bears US NIH Compound Identifier 3950. European Medicines Agency schedules Lomustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08567MIG.

UNSPSC 51112606 Lomustine is a Commodity code covering the procurement of this chemotherapy agent by state and local health systems, correctional facilities, and other public healthcare providers. Lomustine is a nitrosourea-class alkylating agent used in cancer treatment protocols, primarily for brain tumors and lymphomas. State and local procurement under this code encompasses both bulk pharmaceutical supply agreements and unit-dose dispensing arrangements, often coordinated through pharmacy group purchasing organizations or negotiated directly by hospital systems and corrections departments. Issuing bodies include state departments of corrections, county health departments, municipal hospitals, and regional cancer centers that maintain oncology services. The code also captures procurement by state Medicaid agencies and managed-care entities administering pharmacy benefits on behalf of eligible beneficiaries.

The source provided contains no identifiable recent state and local contract opportunities tagged to UNSPSC 51112606. Without posted RFP, RFQ, IFB, or ITB records, geographic concentration and representative recent solicitations cannot be characterized. Firms pursuing this code should monitor state pharmacy cooperative purchasing frameworks, state department of corrections solicitations for institutional pharmacy supplies, and county hospital system RFPs for chemotherapy procurement to identify emerging opportunities.